BLISS GVS PHARMA
Back to Cashflow Statement
|
BLISS GVS PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹106 Cr | ₹103 Cr | ₹34 Cr | ₹135 Cr | ₹64 Cr |
What is the latest Cash Flow from Operating Activities ratio of BLISS GVS PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹106 Cr |
| Mar2024 | ₹103 Cr |
| Mar2023 | ₹34 Cr |
| Mar2022 | ₹135 Cr |
| Mar2021 | ₹64 Cr |
How is Cash Flow from Operating Activities of BLISS GVS PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹106 Cr | 3.01 | |
| Mar2024 | ₹103 Cr | 199.64 | |
| Mar2023 | ₹34 Cr | -74.67 | |
| Mar2022 | ₹135 Cr | 111.79 | |
| Mar2021 | ₹64 Cr | - | |
Compare Cash Flow from Operating Activities of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹2,241.9 Cr | -5.8% | 19.8% | 54.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹417,028.0 Cr | 0.3% | 9% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,237.0 Cr | 1.9% | 5.9% | 12.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,801.0 Cr | 0.6% | 9.5% | 45% | Stock Analytics | |
| CIPLA | ₹108,861.0 Cr | 1.6% | 1.8% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,435.0 Cr | -1.5% | 5.7% | 14.5% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | -5.8% |
19.8% |
54.5% |
| SENSEX | -1.8% |
-1.6% |
7.3% |
You may also like the below Video Courses